IDX
Asset Logo

Integral Diagnostics Limited

πŸ‡¦πŸ‡Ί ASX

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’° Dividends

πŸ’΅ Cost

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

N/A
Annual Growth

5 years average annual growth

πŸ’°

2.00%
Annual dividend yield

Based on the most recent dividend

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

4
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Integral Diagnostics Ltd. engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied professionals. The company is headquartered in Melbourne, Victoria and currently employs 1,868 full-time employees. The company went IPO on 2015-10-21. The company provides diagnostic services to patients and their referrers across Australia and New Zealand. The company operates brands in four Australian States: Lake Imaging in Victoria, the X-Ray Group in VIC/NSW, South Coast Radiology, Peloton Radiology and Imaging Queensland in Queensland and Apex Radiology in Western Australia. The company also operates in New Zealand through the Astra Radiology, SRG Radiology, Horizon Radiology and Trinity MRI brands. Lake Imaging offers a private radiology service to patients throughout Central and Western Victoria. South Coast Radiology provides medical imaging services and patient care to the Gold Coast and Tweed Heads communities. Imaging Queensland is a provider of advanced diagnostic imaging services and radiology education across Queensland. Apex Radiology provides diagnostic imaging services for patients in rural and regional communities.

πŸ“ View Factsheet

πŸ“ˆ Performance

Price History

+82.40%

1M

All Time

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’° Dividends

Payouts

πŸ’° Annual Dividend Yield*

2.00%

πŸ’° Annual Dividend Earnings Per $1,000 invested**

$20.00

πŸ’° Most Recent Dividend Franked Percentage Estimate

100.00%

πŸ’° Average Dividend Franked Percentage Estimate

100.00 %

πŸ’° Dividend reinvestment

Learn more

* Based on the most recent dividend

** Calculated by multiplying the most recent dividend yield by $1,000

Dividend History

1Y

5Y

10Y

Graph

Table

Year
Yearly Dividend Earnings Per Share
Franking Estimate

2024

$0.00

0.00%

2023

$0.00

0.00%

2022

$0.07

100.00%

2021

$0.13

100.00%

2020

$0.10

100.00%

2019

$0.10

100.00%

2018

$0.08

100.00%

2017

$0.07

100.00%

2016

$0.04

100.00%

2015

$0.00

0.00%

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

0%
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$3.44

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in IDX

4

πŸ“Š Total Capital Earnings

N/A

πŸ”ƒ Average investment frequency

N/A

πŸ’΅ Average investment amount

N/A

⏰ Last time a customer invested in IDX

562 days
IDX investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

100%

Less than 50k

πŸ‘Ά Age of investors

18 - 25

26 - 34

25%

35 - 90

75%
πŸ™‹ Legal gender of investors

Female

50%

Male

50%

Pearlers who invest in IDX also invest in...

ETHI

ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.

πŸ“Š Share price

$12.45 AUD

NULL GLOBAL

NULL SMART BETA

NULL ETHICAL

NULL EX AUSTRALIA

Find Out More

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

πŸ“Š Share price

$90.18 AUD

NULL AUSTRALIA

NULL BETA

NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.

πŸ“Š Share price

$34.01 AUD

NULL US

NULL EX AUSTRALIA

NULL BETA

A200

A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 2975.21m in AUM and 200 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.

πŸ“Š Share price

$120.79 AUD

NULL AUSTRALIA

NULL BETA

VESG

VESG.AX was created on 2018-09-11 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Ethically Conscious International Shares Index ETF seeks to track the return of the FTSE Developed ex Australia Choice Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax

πŸ“Š Share price

$73.26 AUD

NULL GLOBAL

NULL SMART BETA

NULL ETHICAL

NULL EX AUSTRALIA

Want more shares? Try these...

IEAT

πŸ“Š Share price

$10.83 AUD

Intra Energy Corp. Ltd. engages in the exploration, development and production of thermal coal. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-07-04. The principal activities of the Company are mineral exploration in Australia and progressing the sale of the Tanzanian coal operations. The company is a developer and producer of thermal coal in Eastern Africa. The company has two subsidiary companies, Tancoal Energy Limited (Tancoal) and Intrafrican Resources Limited (IRL). The company operates the producing thermal coal mine in Eastern Africa through Tancoal in the Ngaka coalfield in Tanzania, a joint venture with the National Development Corporation of Tanzania. The Ngaka Coalfield is situated in the western minerals province of Tanzania, approximately 40 kilometers (km) east of Lake Nyasa. The Company, through its wholly owned subsidiary IRL, is assisting the development of the Minas du Lurio gold concession in Mozambique. The company is a coal supplier to industrial energy users in the Eastern African region through Tancoal.

πŸ“Š Share price

$0.01 AUD

IDEA

πŸ“Š Share price

$2.38 AUD

IDT Australia Ltd. produces, develops and supplies pharmaceutical products. The company is headquartered in Melbourne, Victoria. The firm is engaged in the supply of products and provision of research and development and other technical services within the pharmaceutical and allied industries. Its business includes research and development, active pharmaceutical ingredient (API) and finished dosage form manufacture (FDF), clinical and commercial, project management, chemical services, analytical chemistry, pharmacy services, pharmaceutical development in all dosage forms, clinical packaging and regulatory affairs services. Its Current Good Manufacturing Practice (cGMP) manufacturing facilities can produce both API and FDF positioning it as a facility in the medicinal cannabis manufacturing space. The company also provides a full-scale service for new drug development and scale-up, commercial active drug manufacture as well as a variety of oral and injectable finished drug dose forms. Its analytical laboratories offer medicinal cannabis cGMP testing.

πŸ“Š Share price

$0.09 AUD
Compare
Add to watchlist